Dawn of Destiny

TwelveStone Health Partners Infusion Services Expands to Include Innovative Cancer Treatment Medications

Retrieved on: 
星期四, 十月 5, 2023
Hospital, Dawn of Destiny, Cancer, Snack, Lymphoma, ONS, Kidney, Leukemia, Lung, Oncology Nursing Society, Patient, Pharmaceutical industry, Medical imaging, Durvalumab

MURFREESBORO, Tenn. , Oct. 5, 2023 /PRNewswire-PRWeb/ -- TwelveStone Health Partners, a leading provider of comprehensive chronic care medication services, announced today an expansion of infusion services to include innovative cancer treatments at their Smyrna, Georgia infusion center with plans to also offer the specialty medications in their Murfreesboro, Tennessee location soon. As cancer medications have historically only been administered by hospitals or oncology centers, the announcement holds special significance to those suffering from the dreaded disease.

Key Points: 
  • Rollout Begins in the Smyrna, Georgia Location with Plans to Expand to Tennessee Locations
    MURFREESBORO, Tenn. , Oct. 5, 2023 /PRNewswire-PRWeb/ -- TwelveStone Health Partners, a leading provider of comprehensive chronic care medication services, announced today an expansion of infusion services to include innovative cancer treatments at their Smyrna, Georgia infusion center with plans to also offer the specialty medications in their Murfreesboro, Tennessee location soon.
  • The expansion of infusion services to include cancer treatment is possible through innovative medications like Imfinzi for lung and bladder cancer, Rituxan for lymphoma and leukemia and Opdivo for kidney and bladder cancer that are now available via infusion.
  • "These new medications offer tremendous hope for those managing a cancer diagnosis," said Shane Reeves, chief executive officer at TwelveStone.
  • Learn more about TwelveStone Health Partner's innovative infusion centers here.

TCL Unveils Latest Extra Large Premium QD-Mini LED TV Line up and Smart Home Appliances to Transform Home Entertainment and Inspire Greatness Globally

Retrieved on: 
星期二, 八月 29, 2023
Atmos, Park, Food, Mini, TCL, LED-backlit LCD, Life, QLED, Electronics, Artificial intelligence of things, AC, VRR, HDR, Hygiene, Pesticide, Onkyo, Machine learning, Algorithm, Automatic, Series, Air conditioning, Bacteria, AAT, Dawn of Destiny, Dolby Atmos, Steam, Television, Medical device, Video game

HONG KONG, Aug. 29, 2023 /PRNewswire/ -- TCL, a leading consumer electronics brand and the world's top two TV brand1, today unveiled an impressive lineup of advanced extra-large QD-Mini LED TVs2 and latest smart home announcements to reinvent life at home. TCL continues to enhance everyday experiences and inspire consumers worldwide with its groundbreaking technologies.

Key Points: 
  • TCL continues to redefine the home entertainment landscape, introducing its latest line up of QD-Mini LED TVs as the latest proof point to its commitment to quality and innovation.
  • Equipped with QLED technology, TCL X955 Series produces more than a billion colours and an extensive 98% DCI-P3 colour gamut.
  • Complementing the groundbreaking X955 Series, TCL presented the C955 Series, another standout in the QD-Mini LED TV range.
  • Maintaining global leadership in large-screen TV technology, TCL also presented a new 4K UHD TV, P745, the latest affordable model in large 85" and 98".

TCL Unveils Latest Extra Large Premium QD-Mini LED TV Line up and Smart Home Appliances to Transform Home Entertainment and Inspire Greatness Globally

Retrieved on: 
星期二, 八月 29, 2023
Atmos, Park, Food, Mini, TCL, LED-backlit LCD, Life, QLED, Electronics, Artificial intelligence of things, AC, VRR, HDR, Hygiene, Pesticide, Onkyo, Machine learning, Algorithm, Automatic, Series, Air conditioning, Bacteria, AAT, Dawn of Destiny, Dolby Atmos, Steam, Television, Medical device, Video game

HONG KONG, Aug. 29, 2023 /PRNewswire/ -- TCL, a leading consumer electronics brand and the world's top two TV brand1, today unveiled an impressive lineup of advanced extra-large QD-Mini LED TVs2 and latest smart home announcements to reinvent life at home. TCL continues to enhance everyday experiences and inspire consumers worldwide with its groundbreaking technologies.

Key Points: 
  • TCL continues to redefine the home entertainment landscape, introducing its latest line up of QD-Mini LED TVs as the latest proof point to its commitment to quality and innovation.
  • Equipped with QLED technology, TCL X955 Series produces more than a billion colours and an extensive 98% DCI-P3 colour gamut.
  • Complementing the groundbreaking X955 Series, TCL presented the C955 Series, another standout in the QD-Mini LED TV range.
  • Maintaining global leadership in large-screen TV technology, TCL also presented a new 4K UHD TV, P745, the latest affordable model in large 85" and 98".

Siena College and Gilbane Building Company Celebrate Construction Kickoff With Groundblessing Ceremony

Retrieved on: 
星期二, 六月 27, 2023
Senior, Education, Mission, Siena College, Siena, Gilbane Building Company, Science, Student, Faculty, Dawn of Destiny, Interior design, Management

LOUDONVILLE, N.Y., June 26, 2023 /PRNewswire-PRWeb/ -- Siena College and Gilbane Building Company today jointly hosted a groundblessing ceremony to celebrate the start of construction on an expanded, state-of-the-art science complex at Nobel Hall.

Key Points: 
  • Work Begins on Nobel Hall Science Center Expansion; Construction to Be Completed In 2025
    LOUDONVILLE, N.Y., June 26, 2023 /PRNewswire-PRWeb/ -- Siena College and Gilbane Building Company today jointly hosted a groundblessing ceremony to celebrate the start of construction on an expanded, state-of-the-art science complex at Nobel Hall.
  • Father Mark Reamer, VP of Mission at Siena College, blessed water distributed over the site by the Shaker Road Fire Department.
  • For Siena, the transformative project is step toward its goal of becoming the region's premier college for the hard sciences.
  • "This is an incredibly exciting day as we celebrate the start of construction for Siena College's new state-of-art science complex," said John LaRow, Senior Vice President, Gilbane Building Company.

Charlotte Metro Credit Union to Build New Headquarters Building on Central Avenue and Piedmont Street

Retrieved on: 
星期二, 六月 21, 2022
Uptown, Truliant Federal Credit Union, View, CEO, Charlotte metropolitan area, Metro, Credit union, Central Avenue, Dawn of Destiny, Multimedia, PFCU, Financial services, Bank, Central Branch

CHARLOTTE, N.C., June 21, 2022 /PRNewswire/ -- Charlotte Metro Federal Credit Union (CMCU), a full-service, not-for-profit financial institution headquartered in Charlotte, today announced that it will begin construction on its new primary office building on the corner of Central Avenue and Piedmont Street in Charlotte. The two-story, 48,000 square-foot facility will serve as the credit union's headquarters and home to the growing organization's operations and administration staff which currently deliver financial services for over 92,000 members.

Key Points: 
  • Construction Begins in Early 2023 for a Modern, Two-Story Office Building Which Will Serve as the Credit Union's Primary Operational Offices
    CHARLOTTE, N.C., June 21, 2022 /PRNewswire/ -- Charlotte Metro Federal Credit Union ( CMCU ), a full-service, not-for-profit financial institution headquartered in Charlotte, today announced that it will begin construction on its new primary office building on the corner of Central Avenue and Piedmont Street in Charlotte.
  • Designed by Liquid Design & Architecture, CMCU's new headquarters will feature a modern style, with the use of unique materials and a rain-scene faade.
  • The building will have a large terrace on the second floor facing Uptown Charlotte as well as a two-story atrium space that will enhance visual connectivity between levels.
  • Upon completion of the new headquarters facility, CMCU plans to sell its existing headquarters building at 718 Central Avenue.

WURL PARTNERS WITH SCREENHITS TV TO DELIVER FAST CHANNELS

Retrieved on: 
星期四, 三月 17, 2022
Amazon, LinkedIn, AMC Networks, Android TV, Chromecast, Sony Studios, OTT, Parent, Apple Store, Rakuten, Friends, CNN International, Roku, FAST, Amazon Fire TV, Bloomberg, IOS, CEO, Habit, SVP, A&E Networks, Global Expansion Summit, Churn, VIZIO, Android, Metz, Twitter, Dawn of Destiny, VOD, AMC, News, Child, Television, BBC Studios, Reuters, LG, Communications satellite, Video game, Cable television, Mobile phone, WURL

PALO ALTO, Calif., March 17, 2022 /PRNewswire/ -- March 17, 2022 –  Wurl, the world leader in powering streaming TV, is partnering with ScreenHits TV, a leading global aggregator platform allowing consumers to access all of their VOD and OTT subscriptions in one place, for the global distribution and monetization of FAST channels.

Key Points: 
  • These channels will be distributed on the ScreenHits TV app available across several platforms including on Fire TV, iOS and Android TV now being rolled out across leading smart TV brands to make the best entertainment and news streaming content available on one screen.
  • The announcement was made jointly today by Rose Hulse, Founder and CEO, ScreenHits TV, and Craig Heiting, SVP, Worldwide Business Development at Wurl.
  • "This is an exciting opportunity to join forces with ScreenHits TV, one of the most innovative streaming apps available," said Heiting.
  • "The ability to provide ScreenHits TV's FAST channels to a global audience is helping millions more viewers easily access the very best of streaming content."

NRx Pharmaceutical’s Chairman and Chief Executive Officer Jonathan Javitt to Present Company Business Update at H.C. Wainwright BioConnect Virtual Conference

Retrieved on: 
星期五, 一月 7, 2022
JD, COVID-19, Fast Track, Development, Food, Biotechnology, Novartis, Letter, US Foods, Company, Patient, Goal, Dawn of Destiny, United States Army, J&J, Israel Institute for Biological Research, Lilly, NASDAQ, Health, Biology, Biomedical Advanced Research and Development Authority, BARDA, FDA, Breakthrough therapy, MPH, Board, Dark Enlightenment, GLOBE, Human services, National, ASPE, National Security Advisor (United States), Pharmaceutical industry, Allergan, Conference, Pfizer, MD, Teva

Conference Begins on January 10, 2022

Key Points: 
  • Conference Begins on January 10, 2022
    RADNOR, Pa., Jan. 07, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (NASDAQ:NRXP), a clinical-stage, biopharmaceutical company, todayannounced its Chairman of the Board and Chief Executive Officer, ProfJonathan Javitt, MD, MPH, will be presenting updates to the Companys business at the H.C. Wainwright BioConnect Virtual Conference.
  • Details of the presentation can be found below:
    NRx Pharmaceuticals (NRx) draws upon more than 300 years of collective, scientific, and drug-development experience to bring improved health to patients.
  • The Company is developing the BriLife Covid vaccine, developed by the Israel Institute for Biological Research, under an exclusive license from the Israel Ministry of Defense.
  • NRx is led by executives who have held senior roles at Allergan, J&J, Lilly, Novartis, Pfizer, and the US FDA.